棕榈酸 N-羟基琥珀酰亚胺酯 | 14464-31-4

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 棕榈酸 N-羟基琥珀酰亚胺酯
• 中文别名: 棕榈酸N-羟基琥珀酰亚胺酯；十六烷酸-NHSE
• 英文名称: palmitic acid N-succinimide ester
• 英文别名: palmitic acid succinimidyl ester；2,5-dioxopyrrolidin-1-yl palmitate；palmitic acid N-hydroxysuccinimide ester；palmitic acid NHS ester；(2,5-dioxopyrrolidin-1-yl) hexadecanoate
• CAS: 14464-31-4
• 化学式: C₂₀H₃₅NO₄
• 分子量: 353.502
• InChiKey: OTNHQVHEZCBZQU-UHFFFAOYSA-N

物化性质

• 熔点：
  81°C
• 沸点：
  447.1±28.0 °C(Predicted)
• 密度：
  1.03±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、乙酸乙酯（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  25
• 可旋转键数：
  16
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  63.7
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2925190090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  -20°C，采用惰性气体保存方式。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : Palmitic acid N-hydroxysuccinimide ester
CAS-No. : 14464-31-4
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
Caution - substance not yet tested completely.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : N-(Palmitoyloxy)succinimide
N-Succinimidyl palmitate
Palmitic acid N-succinimidyl ester
Formula : C20H35NO4
Molecular Weight : 353,50 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: -20 °C
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: flakes
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing 86 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  棕榈酸 N-羟基琥珀酰亚胺酯 在 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 (1R,2R)-Hexadecanoic acid [2-(4-benzyloxy-phenyl)-2-hydroxy-1-pyrrolidin-1-ylmethyl-ethyl]-amide
  参考文献：
  名称：

  Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

  摘要：

  披露了一种新型对映合成UDP葡萄糖：N-酰基鞘氨醇葡糖转移酶抑制剂的方法。同时还披露了在合成过程中形成的新型中间体。

  公开号：

  US20030050299A1
• 作为产物：
  描述：

  棕榈酸 以 乙醇 为溶剂， 反应 1.0h， 生成 棕榈酸 N-羟基琥珀酰亚胺酯
  参考文献：
  名称：

  脂肪酸接枝的壳聚糖聚合物及其纳米蛋白的合成和表征，用于非病毒基因递送应用。

  摘要：

  这项研究的目的是合成和表征脂肪酸接枝的壳聚糖（脂肪酸-g-CS）聚合物及其纳米胶束，以用作基因传递的载体。CS使用增加的脂肪酰基链长度的饱和脂肪酸进行疏水改性。碳二亚胺与N-羟基琥珀酰亚胺一起用于将脂肪酸的羧基与CS的胺基偶联。质子核磁共振和傅里叶变换红外光谱用于量化脂肪酰基取代到CS骨架上。使用尺寸排阻高效液相色谱法测定了合成聚合物的分子量分布，发现该分子量在母体CS聚合物的范围内（〜50 kDa）。使用pyr作为荧光探针确定聚合物的临界胶束浓度（cmc）。发现cmc随着脂肪酰基链长度的增加而降低。两亲脂肪酸-g-CS聚合物在水性环境中自组装，形成约200 nm粒径的纳米胶束，并且由于CS分子上游离伯氨基的阳离子性质，其净电荷略微为正。这些高分子纳米胶束分别通过体外溶血和MTT细胞活力测定法表现出优异的血液和细胞相容性，与未修饰的脱乙酰壳多糖和裸露的DNA相比，转染效率更高。这些纳米胶束

  DOI：

  10.1021/acs.bioconjchem.7b00505

文献信息

• Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
  申请人：——

  公开号：US20030229009A1

  公开（公告）日：2003-12-11

  Methods for synthesizing proinsulin polypeptides are described that include contacting a proinsulin polypeptide including an insulin polypeptide coupled to one or more peptides by peptide bond(s) capable of being cleaved to yield the insulin polypeptide with an oligomer under conditions sufficient to couple the oligomer to the insulin polypeptide portion of the proinsulin polypeptide and provide a proinsulin polypeptide-oligomer conjugate, and cleaving the one or more peptides from the proinsulin polypeptide-oligomer conjugate to provide the insulin polypeptide-oligomer conjugate. Methods of synthesizing proinsulin polypeptide-oligomer conjugates are also provided as are proinsulin polypeptide-oligomer conjugates. Methods of synthesizing C-peptide polypeptide-oligomer conjugates and other pro-polypeptide-oligomer conjugates are also provided.

  描述了合成前胰岛素多肽的方法，包括将包括胰岛素多肽和一个或多个肽段的前胰岛素多肽与一个寡聚体接触，这些肽段通过肽键结合，可以被切割以产生胰岛素多肽，条件足以将寡聚体与前胰岛素多肽的胰岛素多肽部分结合并提供前胰岛素多肽-寡聚体共轭物，并从前胰岛素多肽-寡聚体共轭物中切割一个或多个肽段，以提供胰岛素多肽-寡聚体共轭物。还提供了合成前胰岛素多肽-寡聚体共轭物的方法，以及前胰岛素多肽-寡聚体共轭物。还提供了合成C肽多肽-寡聚体共轭物和其他前多肽-寡聚体共轭物的方法。
• Synthetic libraries of tyrosine-derived bacterial metabolites
  作者：Savvas N. Georgiades、Jon Clardy

  DOI：10.1016/j.bmcl.2007.10.058

  日期：2008.5

  The preparation of a collection of 131 small molecules, reminiscent of families of long chain N-acyl tyrosines, enamides and enol esters that have been isolated from heterologous expression of environmental DNA (eDNA) in Escherichia coli, is reported. The synthetic libraries of N-acyl tyrosines and their 3-keto counterparts were prepared via solid-phase routes, whereas the enamides and enol esters

  据报道，制备了 131 个小分子的集合，让人联想到长链 N-酰基酪氨酸、烯酰胺和烯醇酯家族，这些分子是从大肠杆菌环境 DNA (eDNA) 的异源表达中分离出来的。N-酰基酪氨酸及其3-酮对应物的合成库是通过固相途径制备的，而烯酰胺和烯醇酯是在溶液相中合成的。
• Co-liposomes comprising a lipidated multivalent RGD-peptide and a cationic gemini cholesterol induce selective gene transfection in αvβ3 and αvβ5 integrin receptor-rich cancer cells
  作者：Santosh K. Misra、Paturu Kondaiah、Santanu Bhattacharya、Didier Boturyn、Pascal Dumy

  DOI：10.1039/c4tb00701h

  日期：——

  Palmitoylated-RGD4 mediated gene transfer and cell targeting using a cationic gemini cholesterol based liposome.

  通过基于阳离子双胆固醇脂质体的棕榈酰化-RGD4介导的基因转移和细胞靶向。
• Programming Bioactive Architectures with Cyclic Peptide Amphiphiles
  作者：Seah Ling Kuan、Tao Wang、Marco Raabe、Weina Liu、Markus Lamla、Tanja Weil

  DOI：10.1002/cplu.201500218

  日期：2015.8

  synthesis of cyclic peptide amphiphiles of the hormone somatostatin (SST) with tunable lipophilic tails to program bioactive nanoarchitectures. A novel bis-alkylation reagent is synthesized that facilitates the functionalization of SST with a thiol anchor. Different hydrophobic moieties are introduced inspired by a biomimetic palmitoylation approach which opens access to cyclic peptide amphiphiles that

  我们提供了一种通用的方法，用于合成具有可调亲脂性尾巴的激素生长抑素（SST）的环状肽两亲物，以对生物活性纳米结构进行编程。合成了新颖的双烷基化试剂，其促进了具有硫醇锚定的SST的功能化。在仿生棕榈酰化方法的启发下，引入了不同的疏水部分，该方法使人们可以接触显示出丰富的自组织和细胞膜相互作用的环状肽两亲物。
• GLP-2 compounds, formulations, and uses thereof
  申请人：——

  公开号：US20040122210A1

  公开（公告）日：2004-06-24

  The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.

  本发明涉及新型人类胰高血糖素样肽-2（GLP-2）肽和具有持久作用特性的人类胰高血糖素样肽-2衍生物，以及编码这些肽的多核苷酸构建物、包含和表达该多核苷酸的载体和宿主细胞、制药组合物、用途和治疗方法。